Related Experiment Videos
Mucosal repair and COX-2 inhibition
Rafael F Perini1, Li Ma, John L Wallace
1Mucosal Inflammation Research Group, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada. wallacej@ucalgary.ca
Current Pharmaceutical Design
|October 8, 2003
Summary
Cyclooxygenase-2 (COX-2) is vital for gastric ulcer healing. Inhibiting COX-2 can delay healing and hinder blood vessel formation, suggesting caution with selective COX-2 inhibitors in at-risk patients.
Area of Science:
- Gastroenterology
- Cell Biology
- Pharmacology
Background:
- Gastric ulcer healing is a complex biological process.
- Prostaglandins, particularly cyclooxygenase-2 (COX-2), are crucial for this process.
- COX-2 expression increases around ulcer margins, and its inhibition delays healing.
Purpose of the Study:
- To investigate the role of COX-2 in gastric ulcer healing.
- To understand the relationship between COX-2, growth factors, and angiogenesis in ulcer repair.
- To assess the impact of selective COX-2 inhibitors on ulcer healing and angiogenesis.
Main Methods:
- Analysis of COX-2 expression in gastric ulcer margins.
- Evaluation of growth factor involvement in COX-2-dependent healing mechanisms.
- Assessment of serum growth factor levels and angiogenesis following selective COX-2 inhibitor treatment.
Main Results:
- COX-2 expression is significantly upregulated in gastric ulcers.
- COX-2 inhibition delays ulcer healing, potentially via growth factor-mediated pathways.
- Selective COX-2 inhibitors alter growth factor balance, inhibiting angiogenesis.
Conclusions:
- COX-2 plays a critical role in regulating gastric ulcer healing.
- Selective COX-2 inhibitors may impede healing by disrupting angiogenesis.
- Caution is advised when using selective COX-2 inhibitors in patients susceptible to gastric ulcers.